Status:

COMPLETED

A Multi-site Randomized Controlled Trial Comparing Regional and General Anesthesia for Effects on Neurodevelopmental Outcome and Apnea in Infants

Lead Sponsor:

Boston Children's Hospital

Collaborating Sponsors:

Royal Children's Hospital

Royal Hospital for Sick Children

Conditions:

Inguinal Hernia

Eligibility:

All Genders

Up to 60 years

Phase:

PHASE4

Brief Summary

The primary purpose of the GAS study is to determine whether different types of anesthesia (Regional versus General) given to 720 infants undergoing inguinal hernia repair results in equivalent neurod...

Detailed Description

This is a prospective, observer blind, multi-site, randomized, controlled, equivalence trial. The general anesthesia group will receive sevoflurane (intervention drug) for induction and maintenance of...

Eligibility Criteria

Inclusion

  • Any infant scheduled for unilateral or bilateral inguinal hernia repair (with or without circumcision)
  • Any infant whose gestational age is 26 weeks or more (GA = 182 days)
  • Any infant whose post-menstrual age is up to 60 weeks (PMA = 426 days)

Exclusion

  • Any child older than 60 weeks post-menstrual age
  • Any child born less than 26 weeks gestation
  • Any contraindication to general or spinal/caudal anesthesia (for example: neuromuscular disorder or coagulopathy)
  • Pre-operative ventilation immediately prior to surgery
  • Congenital heart disease that has required ongoing pharmacotherapy
  • Known chromosomal abnormality or any other known acquired or congenital abnormalities (apart from prematurity) which are likely to affect development
  • Children where follow-up would be difficult for geographic or social reasons
  • Families where English is not the primary language spoken at home
  • Known neurological injury such as cystic periventricular leukomalacia (PVL), or grade 3 or 4 intra ventricular hemorrhage (ICH) (+/- post hemorrhage ventricular dilation)
  • Previous exposure to volatile anesthesia or benzodiazepines as a neonate or in the third trimester in utero.

Key Trial Info

Start Date :

October 23 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2018

Estimated Enrollment :

643 Patients enrolled

Trial Details

Trial ID

NCT00756600

Start Date

October 23 2006

End Date

June 30 2018

Last Update

April 29 2020

Active Locations (30)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (30 locations)

1

The Children's Hospital Denver

Aurora, Colorado, United States, 80045

2

Children's Memorial Hospital

Chicago, Illinois, United States, 60614

3

The University of Iowa Hospital

Iowa City, Iowa, United States, 52242

4

Children's Hospital Boston

Boston, Massachusetts, United States, 02115